EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

“A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development

Quinn Grundy iD, Chantal Campbell, Ridwaanah Ali, Matthew Herder iD, Kelly Holloway

Journal of Law, Medicine & Ethics · 2024

DOI: 10.1017/jme.2024.51 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, 2024. Verfasst von Quinn Grundy und 4 weiteren Autor:innen. Beteiligte Einrichtung: UNIVERSITY OF TORONTO, TORONTO, ONTARIO, CANADA. Hauptthemen laut MEDLINE: COVID-19 Serotherapy, Immunization, Passive, Public Sector, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Social Sciences and Humanities Research Council of Canada, CIHR, Mitacs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interventional clinical studies of convalescent plasma to treat COVID-19 were predominantly funded and led by public sector actors, including blood services operators. We aimed to analyze the processes of clinical studies of convalescent plasma to understand alternatives to pharmaceutical industry biopharmaceutical research and development, particularly where public sector actors play a dominant role. We conducted a qualitative, critical case study of purposively sampled prominent and impactful clinical studies of convalescent plasma during 2020-2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 SerotherapyImmunization, PassivePublic SectorCOVID-19SARS-CoV-2HumansDrug DevelopmentPandemicsClinical Trials as Topic

Stichwörter der Autor:innen

Clinical TrialsConvalescent PlasmaInnovationPharmaceutical IndustryPublic SectorRandomized Controlled Trials

Autor:innen und Institutionen

  • UNIVERSITY OF TORONTO, TORONTO, ONTARIO, CANADA.
  • DALHOUSIE UNIVERSITY, HALIFAX, NOVA SCOTIA, CANADA.

ORCID-Profile: Quinn Grundy, Matthew Herder

Förderung

  • Social Sciences and Humanities Research Council of Canada
  • CIHR
  • Mitacs

Zitieren

APA

Grundy, Q., Campbell, C., Ali, R., Herder, M., & Holloway, K. (2024). “A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2024.51

Vancouver

Grundy Q, Campbell C, Ali R, Herder M, Holloway K. “A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development. Journal of Law, Medicine & Ethics. 2024. doi:10.1017/jme.2024.51

BibTeX
@article{Grundy2024,
  author = {Grundy, Quinn and Campbell, Chantal and Ali, Ridwaanah and Herder, Matthew and Holloway, Kelly},
  title = {“A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development},
  journal = {Journal of Law, Medicine & Ethics},
  year = {2024},
  doi = {10.1017/jme.2024.51}
}
Kostenlos starten →